Nick Hoogenraad

Biography

  Prof Hoogenraad is former Head of Biochemistry and School of Molecular Sciences (Departments of Biochemistry, Chemistry, Genetics and Pharmacy). He is internationally known for his work on mitochondrial research. He has served on the Boards of the CRC for Diagnostic Technologies, CRC for Diagnostics and the CRC for Vaccine Technologies and TransBio Ltd (CRC for Biomarker Translation). He has been active in translational research and his team was awarded $30.7 million funding to create the CRC for Biomarker Translation funding for the Cooperative Research Centre (CRC) for Diagnostic Technologies. He was President of ASBMB (1997-1998). He was a foundation editor of Today’s Life Science (1989) and established the Australian Biochemist in 1998. He has been active on ARC, ERA panels and NHMRC panels. He has won many major awards for his research, including the ASBMB Lemberg Medal (2004) and AMRAD/Pharmacia Biotechnology Medal (1994); Leach Protein Chemistry Medal (1997). In 2011 he was made an Honorary Life Members of the ASBMB. In 2014 he was awarded an AO for his contributions to science education and research. In 2009 he led a successful bid for an EIF application for $64.1 million for the creation of the La Trobe Institute for Molecular Science (LIMS; completed Nov., 2012) where he took on the additional role as Executive Director of LIMS. In 2010 he was awarded a Charles La Trobe Distinguished chair in Biochemistry for his sustained contribution to La Trobe University. Since 2008 his interests became increasingly focused on the cause of cancer cachexia leading to the discovery of the Fn14 receptor as the cause of this condition. He and his team developed monoclonal antibodies against the receptor which have proven to be therapeutic in preclinical.  

Research Interest

Biomarker